Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Fibronectin based scaffold proteins Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Antisense oligonucleotides targeting alpha-synuclein and uses thereof Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Substituted indole compounds useful as inhibitors of TLR7/8/9 Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Spiroheptanyl hydantoins as rock inhibitors Filling date: 5 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Aminoimidazopyridazines as kinase inhibitors Filling date: 5 Sep 2025 Issue date: 13 Sep 2022 |
Application | Utility: TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 5 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 5 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: Fast-off rate serum albumin binding fibronectin type III domains Filling date: 5 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE Filling date: 5 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 5 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: 6-azaindole compounds Filling date: 5 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 5 Sep 2025 Issue date: 30 Aug 2022 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: THIENOPYRIDINYL AND THIAZOLOPYRIDINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: PYRAZOLO[3,4-D]PYRROLO[1,2-B]PYRIDAZINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Grant | Utility: Aryl and heteroaryl substituted indole compounds Filling date: 5 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Amide substituted indole compounds useful as TLR inhibitors Filling date: 5 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids Filling date: 5 Sep 2025 Issue date: 23 Aug 2022 |
Application | Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF IDENTIFYING A SUBJECT SUITABLE FOR AN IMMUNO-ONCOLOGY (I-O) THERAPY Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Grant | Utility: Compounds useful as immunomodulators Filling date: 5 Sep 2025 Issue date: 16 Aug 2022 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 5 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ANTI-CTLA4 ANTIBODY PRODRUGGABLE (PROBODY) AT A CDR POSITION Filling date: 5 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: IMMUNOMODULATORS Filling date: 5 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Anti-GITR antibodies for cancer diagnostics Filling date: 5 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Fibronectin binding domains with reduced immunogenicity Filling date: 5 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Stabilized fibronectin based scaffold molecules Filling date: 5 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: 2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor Filling date: 5 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Methods of minimizing glycoprotein agregation in CHO cell production Filling date: 5 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: Antibody Compositions and Methods of Use Thereof Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHODS OF TREATING TUMORS Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ISOXAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CYCLOBUTYL CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: TRIAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CRYSTALLINE SALT FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYLD3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CELL LOCALIZATION SIGNATURE AND COMBINATION THERAPY Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Grant | Utility: Apelin receptor agonists and methods of use Filling date: 5 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: METHODS OF MONITORING CELL CULTURE MEDIA Filling date: 5 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METHODS FOR REGENERATING CHROMATOGRAPHY RESINS Filling date: 5 Sep 2025 Issue date: 14 Jul 2022 |
Grant | Utility: Methods for treating costimulation blockade resistant rejection Filling date: 5 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Pyrazole n-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 5 Sep 2025 Issue date: 12 Jul 2022 |
Application | Utility: METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 5 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: PRODRUG COMPOUNDS Filling date: 5 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS Filling date: 5 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 30 Jun 2022 |
Showing 1 to 50 of 772 patents.